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Brief Definitive Report

Type I interferon negatively controls
plasmacytoid dendritic cell numbers in vivo
Melissa Swiecki,1 Yaming Wang,1 William Vermi,2 Susan Gilfillan,1
Robert D. Schreiber,1 and Marco Colonna1
1Department

of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110
of Pathology, University of Brescia, 25121 Brescia, Italy

Plasmacytoid dendritic cells (pDCs) specialize in the secretion of type I interferons (IFN-I) and
thus are considered critical mediators of antiviral responses. We recently reported that pDCs
have a very early but limited and transient capacity to curtail viral infections. Additionally,
pDC numbers are not sustained in human infections caused by Hepatitis B or C viruses (HBV
and HCV) and HIV. Thus, the numbers and/or function of pDCs appear to be regulated during
the course of viral infection. In this study, we show that splenic pDCs are reduced in vivo
during several systemic viral infections and after administration of synthetic toll-like receptor ligands. We demonstrate that IFN-I, regardless of the source, contributes to this decline
and mediates pDC death via the intrinsic apoptosis pathway. These findings demonstrate a
feedback control mechanism by which IFN-I modulates pDC numbers, thus fine-tuning
systemic IFN-I response to viruses. IFN-I–mediated control of pDCs may explain the loss of
pDCs during human infections caused by HBV, HCV, or HIV and has important therapeutic
implications for settings in which IFN-I is used to treat infections and autoimmune diseases.
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Abbreviations used: DR5, death
receptor 5; LCMV, lymphocytic
choriomeningitis virus; MCMV,
murine cytomegalovirus; pDC,
plasmacytoid DC; p.i., post
infection; poly(I:C), polyinosinic:polycytidylic acid; TLR,
Toll-like receptor; TRAIL,
TNF-related apoptosis-inducing
ligand; VACV, vaccinia virus;
VSV, vesicular stomatitis virus.

Plasmacytoid DCs (pDCs) are bone marrow–
derived cells that specialize in the secretion of
type I IFNs (IFN-I). pDCs detect RNA and
DNA viruses through two endosomal sensors,
toll-like receptor (TLR) 7 and TLR9, respectively, which induce secretion of IFN-I through
the MyD88–IRF7 signaling pathway (Gilliet
et al., 2008). IFN-I confers resistance to viral infections and promotes NK cell, DC, T cell, and
B cell functions (García-Sastre and Biron, 2006).
In addition to secreting IFN-I, pDCs produce IL-12, IL-6, and chemokines that contribute to innate and adaptive immune responses
(Trinchieri, 2010). pDCs also express major
histocompatibility complex and costimulatory
molecules, and therefore may directly participate in presentation and cross-presentation of
antigens to T cells (Villadangos and Young,
2008). Thus, pDCs have been implicated in both
innate and adaptive immunity.
In mice, it has been reported that pDC
numbers decline in spleens after TLR7/9 stimulation and during certain viral infections such
as murine cytomegalovirus (MCMV) and lymphocytic choriomeningitis virus (LCMV;
Asselin-Paturel et al., 2005; Zuniga et al., 2008;
Lee et al., 2009). Decreased numbers of circulating pDCs have been observed in patients
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infected with Hepatitis B or C viruses (Duan
et al., 2004; Kanto et al., 2004). pDC numbers
are also reduced in the blood of patients infected with HIV. Loss of pDCs correlates with
high viral load, decreased CD4+ T cell counts,
and the onset of opportunistic infections (Finke
et al., 2004; Altfeld et al., 2011). At present, it
is unclear what factors are responsible for the
diminution of pDCs during human infections.
pDCs could be direct targets of HIV because
they express the HIV receptors and/or they
may migrate into secondary lymphoid tissues
where they undergo apoptosis by yet un
defined mechanisms (Fonteneau et al., 2004;
Malleret et al., 2008; Brown et al., 2009).
In this study, we investigated the turnover
of pDCs in vivo during several systemic viral
infections. We observed a marked reduction in
splenic pDCs in infected mice, which inversely
correlated with systemic levels of IFN-I. Viral
infection induced the up-regulation of proapoptotic molecules in pDCs in an IFN-I–dependent
manner resulting in caspase activation and death.
© 2011 Swiecki et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after
the publication date (see http://www.rupress.org/terms). After six months it is
available under a Creative Commons License (Attribution–Noncommercial–Share
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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These findings unveil a novel feedback control mechanism
by which IFN-I modulates pDC numbers in vivo for preventing excessive systemic IFN-I response to viruses.

IFN-I signaling induces pDC activation and death in vivo
To test whether the decline in pDC numbers during infection
was related to pDC activation, death, and/or IFN-I signaling,
we infected WT and IFNAR/ mice with HSV-1 and then
assessed frequencies of splenic pDCs (CD11c+Siglec-H+) and
their expression of PDC-TREM and caspase. PDC-TREM is
an early activation marker expressed by pDCs that is induced

Figure 1. Decline of splenic pDCs during
systemic viral infections. Mice were infected
with RNA or DNA viruses and absolute numbers of pDCs and serum IFN- levels were
determined at different time points p.i.
(A) C57BL/6 mice were infected with 107 pfu
HSV-1. Data are representative of two experiments with four mice per time point.
(B) C57BL/6 mice were infected with 5 × 106
pfu VSV-OVA. Data are representative of two
experiments with four mice per time point.
(C) C57BL/6 mice were infected with 5 × 104
pfu MCMV. Data are combined from two experiments with five to six mice per time point.
(D) Spleen sections from uninfected (Ctrl) and
MCMV-infected C57BL/6 mice were stained
for Siglec-H (blue) and CD3 (brown). A magnification is shown in the inset. Bar, 100 µm.
The graph shows mean pDC numbers per high
power field (HPF) in Ctrl and MCMV-infected
spleen sections (n = 8). (E) pDC numbers in
spleens and serum IFN- levels were determined from C57BL/6 (5 × 104 pfu MCMV; 104 pfu m157) and 129/SvJ (104 pfu MCMV) mice infected or not
for 48 h (n = 4–5 mice per group). (F) C57BL/6 mice were infected with 3 × 106 pfu LCMV clone 13. Data are combined from two experiments with six to
eight mice per time point. (G) C57BL/6 mice were infected with 2 × 106 pfu VACV. Data are representative of two experiments with three to five mice per
time point. (A–C and E–G) Error bars represent means ± SEM. (A, F, and G) pDC numbers, black bars; IFN- levels, white bars. (B and C) pDC numbers,
open squares; IFN- levels, closed circles. (D) Statistical significance is indicated by **, P < 0.001. Error bars represent means ± SD.
2368
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RESULTS AND DISCUSSION
pDCs are reduced during systemic viral infections
that induce IFN-I
To investigate the fate of pDCs during systemic viral infections,
we infected C57BL/6 mice with disparate RNA or DNA viruses known to activate pDCs through the TLR7/9–MyD88–
IRF7 pathway and monitored pDC numbers (B220+Siglec-H+
or CD11c+Siglec-H+) and systemic IFN- levels at different
time points post infection (p.i.). Flow cytometric analysis of
spleens from HSV-1–infected mice revealed a decrease in pDCs
compared with uninfected animals that was paralleled by an increase in serum IFN- levels (Fig. 1 A). The reduced numbers
of pDCs were not a result of the down-regulation of Siglec-H
and therefore the inability to detect pDCs, as SiglecH-eGFP
gene-targeted mice also had decreased numbers of GFP+ pDCs
after infection with HSV-1 (unpublished data). HSV-1 infection in other mouse strains also led to reduced numbers of
pDCs, suggesting that the decline of pDCs after systemic virus
infection is not strain dependent (unpublished data).
Infection with vesicular stomatitis virus (VSV) expressing
OVA (VSV-OVA) or MCMV also resulted in the reduction of
splenic pDCs during the first few days of infection when
IFN- levels were abundant in the serum (Fig. 1, B and C).
To corroborate our flow cytometry data, we evaluated pDC
numbers in spleens by histology. Frozen tissue sections of
spleens obtained from control and MCMV-infected (36 h p.i.)
mice stained with anti–Siglec-H showed numerous pDCs,

mainly located in the white pulp (Fig. 1 D). Consistent with
flow cytometry data, we found a significant reduction in the
number of pDCs in MCMV-infected mice (Fig. 1 D). Lack of
pDCs was heterogeneous, with areas of white pulp almost completely devoid of Siglec-H+ cells (Fig. 1 D). The residual pDC
population was occasionally found to form microclusters surrounding the periarteriolar lymphoid sheets (unpublished data).
Interestingly, in mice lacking efficient NK cell responses
to MCMV (129/SvJ), we observed increased levels of systemic IFN- and a more profound reduction in pDC numbers
compared with MCMV-infected C57BL/6 mice (Fig. 1 E). Infection with LCMV clone 13, which establishes a chronic
infection in mice, caused a transient drop in splenic pDC
numbers around the time when IFN- concentrations peak
in the serum (Fig. 1 F), consistent with previous results
(Zuniga et al., 2008; Lee et al., 2009). Our data suggests that
pDC numbers plummet when IFN-I levels are prevalent in
the serum and begin to recover when systemic IFN-I is no
longer detectable. Thus, IFN-I might contribute to the rapid
decline of pDCs during certain viral infections. In support of
this, infection with vaccinia virus (VACV) did not elicit high
levels of systemic IFN-I or cause a dramatic reduction in
pDC numbers (Fig. 1 G).
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by TLR and IFN-I signaling (Watarai et al., 2008), whereas
caspase activation is indicative of apoptosis. In HSV-1–
infected WT mice, the frequencies of pDCs fell more than twofold and those pDCs remaining expressed more PDC-TREM
on the cell surface than pDCs from control mice (Fig. 2 A).
Using a pan-caspase inhibitor that is an in situ marker for
apoptosis, we found that 37% of pDCs from infected WT
mice were caspase+ compared with 11% in uninfected mice.
In IFNAR/ mice infected with HSV-1, the frequencies of
splenic pDCs were comparable to uninfected IFNAR/
mice (0.4 and 0.5, respectively) and there was no up-regulation

of PDC-TREM or differences in caspase activation in pDCs
from control and infected animals (Fig. 2 B).
Quantitative analysis of pDC numbers in control and
HSV-1–infected mice revealed a greater reduction in WT
mice compared with IFNAR/ mice (Fig. 2 C). Concomitantly, when IFN-I signaling was blocked with anti-IFNAR
mAb in WT mice before infection with HSV-1, pDC numbers and survival remained similar to those found in uninfected
mice (Fig. 2 D). To validate that pDCs were in fact under
going apoptosis in an IFN-I–dependent manner, we evaluated
both caspase+ and Annexin V+ pDCs in WT and IFNAR/

Downloaded from jem.rupress.org on February 14, 2012

Figure 2. pDCs undergo cell death during systemic HSV-1 infection in an IFN-I–dependent manner. (A and B) C57BL/6 (A) and IFNAR/
(B) mice were infected with 107 pfu HSV-1 for 8 h. Control mice were uninfected. pDC frequencies in spleens, expression of PDC-TREM, and caspase activation in pDCs were measured by flow cytometry. Dot plots and histograms show data from three to five mice per genotype representative of three experiments. (C) pDC numbers in spleens from C57BL/6 and IFNAR/ mice infected or not with 107 pfu HSV-1 for 8 h. Data are representative of three
experiments with three to five mice per group. Percentages denote the reduction in pDC numbers in infected mice relative to controls. (D) C57BL/6 mice
were treated with an isotype control mAb or anti-IFNAR mAb 4 h before infection with 107 pfu HSV-1. Bar graphs show absolute numbers of pDCs (left)
and frequencies of caspase+ pDCs (right) in control and infected mice 8 h p.i. Data are representative of two experiments with three to four mice per
group. Percentages indicate the reduction in pDC numbers in infected mice relative to controls. Statistical significance is indicated by ***, P < 0.0001.
(E) C57BL/6 and IFNAR/ mice were infected or not with 107 pfu HSV-1 for 8 h. Caspase+ and Annexin V+ pDCs were determined by flow cytometry. Data
are representative of two experiments with three to four mice per group. Statistical significance is indicated by ***, P ≤ 0.0006. (F) MyD88/ mice were
infected or not with 107 pfu HSV-1. pDC frequencies in spleens, expression of PDC-TREM, and caspase activation in pDCs were measured by flow cytometry 8 h p.i. Dot plots and histograms show data from three to five mice per group representative of two experiments. (G and H) Mice of the indicated
genotype were infected or not with 107 pfu HSV-1 for 8 h. Bar graphs show frequencies of caspase+ pDCs in spleens (G) and serum IFN- levels (H). Data
are combined from two experiments with four to eight mice per genotype. Statistical significance is indicated by **, P < 0.007; ***, P < 0.0007. (I) C57BL/6
mice were infected or not with different doses of HSV-1 (107, 106 or 105 pfu) for 8 h. pDC numbers in spleens, serum IFN- levels, and Annexin V+ pDCs
were determined. Data are from representative of two experiments with three to four mice per group. (C–E and G–I) Error bars represent means ± SEM.
JEM Vol. 208, No. 12
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Sources of IFN-I that promote pDC death
Given that pDCs are a source of IFN-I during HSV-1 infection (Krug et al., 2004), we asked whether caspase activation
in pDCs is dependent on pDC-derived IFN-I and/or alternative IFN-I sources. Studies in pDC-depleted mice (Swiecki
et al., 2010) revealed that pDCs are a major source of IFN-
early during HSV-1 infection but not at later time points
(Fig. 3 A and not depicted), suggesting that pDCs produce
the IFN-I that induces their death. To evaluate this, we looked
at IFN- levels and caspase activation in mice injected with
the synthetic ligands CpGA and polyinosinic:polycytidylic
acid (poly(I:C)). CpGA elicits IFN-I in pDCs through TLR9,
whereas poly(I:C) induces IFN-I production from cDC
and/or macrophages and stromal cells via TLR3 and MDA5,
respectively (Gilliet et al., 2008; Longhi et al., 2009). We
found that depleting pDCs has an impact on IFN- production in response to CpGA but not poly(I:C) (Fig. 3 B),
whereas administration of either ligand resulted in pDC activation and death (Fig. 3 C).
We next asked whether the direct administration of IFN-I
impacts pDC numbers in vivo. To test this, WT and IFNAR/
mice were injected with recombinant IFN- and IFN-5,
and pDC numbers, as well as pDC expression of caspase and
2370

Figure 3. IFN-I–mediated death of pDCs does not depend on the
IFN-I source. (A) BDCA2-DTR Tg mice were injected with PBS or DT before
107 pfu HSV-1. Serum IFN- levels were measured by ELISA 6 h p.i. Data
are combined from two experiments with five mice per group. (B) BDCA2DTR Tg mice were injected with PBS or DT before CpGA or poly(I:C). Serum
IFN- levels were determined by ELISA 8 h after CpGA or 8 and 24 h after
poly(I:C). Data are representative of two experiments with four to five mice
per group. (C) BDCA2-DTR Tg mice were injected with CpGA or poly(I:C)
and pDC frequencies in spleens, expression of PDC-TREM, and caspase
activation were measured by flow cytometry 8 h after CpGA or 16 h after
poly(I:C) administration. Dot plots and histograms show data from three to
four mice per group representative of two experiments. Statistical significance is indicated by **, P < 0.008. (D and E) C57BL/6 and IFNAR/ mice
were injected with recombinant mouse IFN-I. (D) Dot plots show frequencies of pDCs in spleens 12 h after injection. (E) Absolute numbers of pDCs
(left) as well as caspase+ and Annexin V+ pDCs in spleens (right) 12 h after
injection. Data are representative of two experiments with three mice per
group. Statistical significance is indicated by **, P < 0.006; ***, P ≤ 0.0008.
(A, B, and E) Error bars represent means ± SEM.

Annexin V, were determined. The frequencies and numbers
of pDCs declined in IFN-I–treated WT mice but not
IFNAR/ mice (Fig. 3, D and E). Furthermore, we detected
more caspase+ and Annexin V+ pDCs in WT mice treated
with IFN-I compared with IFNAR/ mice (Fig. 3 E).
Thus, our findings indicate that although pDCs can be a
source of IFN-I that induces pDC death, additional sources
of endogenous, as well as exogenous, IFN-I can regulate pDC
numbers in vivo.
Type I interferon mediates death of pDC | Swiecki et al.
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mice infected with HSV-1. Frequencies of caspase+ and
Annexin V+ pDCs were significantly higher in infected WT
mice compared with infected IFNAR/ mice (Fig. 2 E). Collectively, these data show that pDC activation and death during
systemic viral infection are dependent on IFN-I signaling.
To establish the impact of TLR signaling on pDC survival, we infected MyD88/ mice i.v. with HSV-1. Infected
MyD88/ mice had an intermediate phenotype between
that of infected WT and IFNAR/ mice (Fig. 2 F). pDC
frequencies were partially reduced compared with uninfected
controls but not to the extent observed in WT mice. Similarly,
minor fractions of pDC from HSV-1–infected MyD88/
mice were caspase+ compared with uninfected mice and to
pDCs from infected WT mice. In contrast to IFNAR/
pDCs, MyD88/ pDCs up-regulated PDC-TREM during
HSV-1 infection. The differences in caspase activation observed in pDCs from WT versus IFNAR/ and MyD88/
mice correlated with systemic IFN- levels. On average, the
frequencies of caspase+ pDCs in WT mice approached 40%,
compared with 14 and 20% in IFNAR/ and MyD88/
mice, respectively (Fig. 2 G). Following that trend, serum
IFN- levels in WT mice were 4.0 ng/ml, whereas
IFNAR/ and MyD88/ mice had levels of 0.3 and
0.8 ng/ml, respectively (Fig. 2 H). Thus, during systemic
HSV-1 infection, MyD88 signaling contributes in part to systemic IFN- levels and pDC death but not to pDC activation as measured by PDC-TREM expression. Finally, we
determined whether pDC survival was impacted by the dose
of HSV-1 inoculum. As virus inoculum increased, pDC numbers declined, whereas serum IFN- levels and Annexin V+
pDCs increased (Fig. 2 I). These data indicate that pDC death
correlates with viremia and systemic IFN- levels.
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Figure 4. pDCs up-regulate extrinsic and intrinsic apoptotic proteins in an IFN-I–dependent manner during systemic HSV-1 infection. (A–I) Mice were infected or not with 107 pfu HSV-1. (A) Expression of
Fas and DR5 on pDCs from spleens was determined 8 h p.i. Histograms
show data from three to five mice per group from two experiments.
(B) FasL expression on NK, NKT, and T cells from spleens of control and
HSV-1–infected C57BL/6 mice 8 h p.i. Histograms show data from three to
five mice per group from three experiments. (C) C57BL/6 mice were
treated or not with anti-FasL mAb before HSV-1 infection. Bar graphs
show serum IFN- levels (left) and frequencies of caspase+ pDCs (right) in
spleens 8 h p.i. (D) C57BL/6 mice were treated or not with anti-TRAIL mAb
before HSV-1 infection. Bar graphs show serum IFN- levels (left) and
frequencies of caspase+ pDCs (right) in spleens 8 h p.i. (E) Granzyme B
(GrB) expression on NK, NKT, and T cells from spleens of control and HSV-1–
infected C57BL/6 mice 8 h p.i. Histograms show data from three to five
mice per group from two experiments. (F) Mice were depleted of NK1.1+
cells before HSV-1 infection. Dot plots show frequencies of pDCs and
histograms show frequencies of caspase+ pDCs in spleens 8 h p.i. Data
are representative of two experiments with four mice per group.
(G and H) C57BL/6 and IFNAR/ mice were infected or not with HSV-1,
RNA was isolated from pDCs sorted from spleens 4 h p.i., and relative levels
of pro- and antiapoptotic molecules were measured in duplicate by qPCR.
(G) Relative expression in naive (left) and HSV-1–infected (right) pDCs.
(H) Fold change in WT and IFNAR/ mice. (I) Absolute numbers of pDCs in
JEM Vol. 208, No. 12

Systemic HSV-1 infection induces pDC expression
of proapoptotic molecules in an IFN-I–dependent manner
We next evaluated the expression of molecules involved in
the intrinsic apoptosis pathway. The Bcl-2 family is composed
of several proteins that exert either pro- or antiapoptotic functions (Youle and Strasser, 2008). To ascertain whether IFN-I
induced the expression of proapoptotic molecules in pDCs
during systemic HSV-1 infection, we isolated RNA from
pDCs sorted from naive and HSV-1–infected WT and
IFNAR/ mice and then measured transcripts for pro- and
antiapoptotic molecules by quantitative (q) PCR (Fig. 4 G).

spleens were determined in C57BL/6, IFNAR/, and Bim/Bid/ mice 8 h
p.i. The bar graph shows the percent reduction in pDCs in HSV-1–infected
mice compared with controls. Data are combined from two experiments
with four mice per group. Statistical significance is indicated by **, P <
0.005. (C and D) Data are representative of two experiments with three to
five mice per group. (G and H) Data are representative of two experiments
where pDCs were sorted and pooled from three mice per genotype.
(C, D, and G–I) Error bars represent means ± SEM.
2371
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pDC death occurs independently of the extrinsic
apoptosis pathway
We next evaluated potential mechanisms leading to IFN-I–
dependent caspase induction in pDCs. IFN-I induces the expression of Fas and TNF-related apoptosis-inducing ligand
(TRAIL) which, through Fas/FasL and TRAIL/death receptor 5 (DR5) interactions, induce apoptosis via the extrinsic
pathway. Using WT and IFNAR/ mice infected i.v. with
HSV-1, we found that a fraction of pDCs from WT, but not
IFNAR/, mice up-regulated Fas, whereas pDCs from both
groups expressed very low levels of DR5 (Fig. 4 A). TRAIL
and FasL were not clearly detectable on pDCs from any of
the groups (unpublished data). FasL was detected at minimal
levels on NK and NKT cells during HSV-1 infection (Fig. 4 B),
which prompted us to examine whether caspase activation
and pDC death might be mediated by Fas/FasL interactions
with either NK or NKT cells. Disrupting Fas/FasL inter
actions by Ab blockade did not impact IFN- responses to
HSV-1 or prevent caspase activation in pDCs (Fig. 4 C).
Although we could not detect TRAIL on NK cells or
pDCs, we attempted to block any potential TRAIL/DR5
interactions in vivo with an anti-TRAIL mAb before infecting mice with HSV-1. Blocking TRAIL had no impact on
IFN- production or caspase activation in pDCs (Fig. 4 D).
We also asked whether NK or NKT cells might kill pDCs via
perforin/granzyme, which can be induced by IFN-I during
virus infections (García-Sastre and Biron, 2006). Although
NK and NKT cells up-regulated granzyme B during HSV-1
infection (Fig. 4 E), depletion of NK1.1+ cells before HSV-1
infection did not have an impact on pDC frequencies or caspase activation (Fig. 4 F). Collectively, these data suggest that
pDC death is independent of Fas/FasL or TRAIL/DR5
interactions and NK or NKT cell cytolytic activity during
HSV-1 infection.
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Concluding remarks
In this study, we found that pDCs are reduced in vivo during
several systemic viral infections. Mechanistically, we observed
that IFN-I, regardless of the source, mediates pDC death
in vivo by inducing the expression of proapoptotic molecules
and caspase activation in pDCs. Previous studies have demonstrated that IFN-I signaling promotes the survival of mouse
and human pDCs ex vivo, and activates pDCs and induces
their migration in vivo (Kadowaki et al., 2000; AsselinPaturel et al., 2001, 2005). Thus, the distinct outcomes of
IFN-I signaling on pDCs suggest that pDC responses to IFN-I
are influenced by the microenvironment. It has been shown
that IFN-I regulates turnover of classical DCs in vivo by inducing the up-regulation of proapoptotic molecules and caspase activation (Mattei et al., 2009; Yen and Ganea, 2009;
Fuertes Marraco et al., 2011). Impairment in DC turnover
leads to increased numbers of DCs, chronic lymphocyte activation, and manifestations of autoimmunity (Nopora and
Brocker, 2002; Chen and Wang, 2010). Similarly, the rapid
turnover of pDCs during an IFN-I response in vivo may prevent excessive IFN-I–mediated cellular activation, immunopathology, and perhaps autoimmunity.
Our findings may explain the loss of pDCs during viral
infections such as HIV, in which protracted deletion of pDCs
might contribute to immunodeficiency. pDC numbers are
reduced in patients with HIV but can be partially restored after
antiretroviral therapy (HAART; Finke et al., 2004). Thus,
HAART may reduce viral burden and systemic IFN-I levels
improving the survival of pDCs during HIV infection (Boasso
and Shearer, 2008). HIV infection may also affect pDC function
or induce pDC anergy independently of IFN-I signaling, similar
to what has been observed in experimental models of chronic
viral infection with LCMV clone 13 (Zuniga et al., 2008;
2372

Lee et al., 2009). Current treatments for chronic Hepatitis C
virus (HCV) infection include IFN- in combination with
ribavirin. Interestingly, it has been reported that blood pDCs
are reduced in HCV patients receiving IFN- therapy compared with untreated patients (Goutagny et al., 2004). Our
findings suggest that treatment with IFN-I may also negatively regulate pDC numbers during human infections.
MATERIALS AND METHODS
Mice and treatments. All animal studies were approved by the Washington
University Animal Studies Committee. IFNAR/ mice (C57BL/6 background) were provided by A. French (Washington University, St. Louis,
MO). Bim/ and Bid/ mice have been previously described (Bouillet
et al., 1999; Kaufmann et al., 2007) and were provided by A. Strasser (Walter
and Eliza Hall Institute, Victoria, Australia). C57BL/6, BDCA2-DTR Tg
and 129/SvJ were bred in house. Heterozygous SiglecH-eGFP genetargeted mice on a 129/SvJ background have been recently described and
were bred in house (Swiecki et al., 2010). MyD88/ mice (C57BL/6 background) were bred in house. All mice were used at 6–12 wk of age. Diphtheria toxin (DT; Sigma-Aldrich) was injected i.p. into BDCA2-DTR Tg
mice (100–120 ng/mouse) 24 h before HSV-1, CpGA, or poly(I:C) administration. Approximately 200 µg PK136 mAb was injected i.p. 48 h
before HSV-1 infection. Purified anti-FasL mAb (CD178, clone MFL3;
BioLegend) or purified anti-TRAIL mAb (CD253, clone N2B2; BioLegend)
were injected i.v. at 100 µg per mouse 20 h before HSV-1 infection. AntiIFNAR and isotype control mAbs were injected i.v. at 625 µg per mouse 4 h
before HSV-1. Recombinant mouse IFN- and IFN-5 were gifts from D.
Fremont (Washington University, St. Louis, MO). Mice were injected i.v.
with 15,000 U of both IFN- and IFN-5.
In vivo infections and stimulations. Kos strain HSV-1, Smith strain
MCMV, MCMV AT1.5 (m157), Indiana strain VSV-OVA, LCMV clone 13,
and VACV were provided by D. Leib (Dartmouth College, Hanover,
NH), W. Yokoyama (Washington University, St. Louis, MO), A. French
(Washington University, St. Louis, MO), L. Lefrançois (University of Connecticut, Farmington, CT), R. Ahmed (Emory University, Atlanta, GA), and
L. Deng (Sloan-Kettering, New York, NY), respectively. Salivary gland
stocks of MCMV and AT1.5 were administered i.p. HSV-1, and VSV-OVA,
LCMV clone 13, and VACV were injected i.v. Administered doses of viruses
are described in the figure legends. 6–9 µg CpGA 2216 (Operon) complexed
with 30 µl DOTAP (Roche) was injected i.v. in phosphate-buffered saline.
Poly(I:C) (GE Healthcare) was injected i.v. at 200 µg per mouse.
Cell preparations. Spleens were minced and digested for 45 min at 37°C
in RPMI 1640 with collagenase D (Sigma-Aldrich). Single cell suspensions
of spleens were prepared by passage through nylon mesh cell strainers (BD).
EDTA was only used in MACS buffer for cell enrichment before sorting.
Red blood cells were lysed with RBC lysis buffer (Sigma-Aldrich). Serum
was separated from whole blood in serum collection tubes and stored at
20°C until analysis.
Antibodies, flow cytometry, and cell sorting. The following reagents
were obtained from BD, eBioscience, or BioLegend. Fluorochrome labeled
anti-SiglecH (551), anti-B220 (RA3-6B2), anti-CD11c (HL3), anti-Ly6C
(AL-21), anti-CD3 (145-2C11), anti-NK1.1 (PK136), anti–Granzyme B
(GB11), anti-CD262 (DR5, MD5-1), anti-CD178 (FasL, MFL3), antiCD95 (Fas, clone 15A7), anti-CD253 (TRAIL, clone N2B2), and Strepta
vidin. Anti–PDC-TREM (clone 162.7, rat IgG2a) was purified from ascites
and biotinylated using the FluoReporter Minibiotin kit (Invitrogen). Fc receptors were blocked before surface staining with supernatant from HB-197
cells (American Type Culture Collection). Propidium iodide was used to
determine pDC frequencies and numbers during virus infections shown in
Fig. 1. Propidium iodide was not used in caspase activation or Annexin V
experiments. All flow cytometry was conducted on a dual laser FACSCalibur
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We found that pDCs from infected WT mice strongly upregulated Bid, Bim, Noxa, and Bax while down-regulating
Bcl-xl and Bcl-2 compared with pDCs from naive WT mice
(Fig. 4 H). In contrast, pDCs from infected IFNAR/ mice
displayed little to no change in the expression of proapoptotic
molecules compared with pDCs from naive IFNAR/ mice,
although, they did increase their expression of Bcl-xl and decrease their expression of Bcl-2 (Fig. 4 H).
We then asked if pDCs from mice deficient for components
of the intrinsic pathway were more resistant to apoptosis after
HSV-1 infection. To test this, we infected WT, IFNAR/,
and Bim/Bid/ mice with HSV-1 and determined pDC
numbers 8 h p.i. pDC numbers were reduced 60% in WT mice
and 8% in IFNAR/ mice infected with HSV-1 (Fig. 4 I). In
Bim/Bid/ mice, pDC numbers were reduced 35%, indicating that in the absence of these two proapoptotic proteins
pDC numbers were partially maintained. These data demonstrate that IFN-I generated during systemic HSV-1 infection
induces the expression of proapoptotic molecules in pDCs
leading to caspase activation and cell death. Deficiency in
components of the intrinsic apoptosis pathway results in increased survival of pDCs during systemic HSV-1 infection.
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flow cytometer (BD) and analyzed with FlowJo software (Tree Star). For
pDC sorting from HSV-1–infected mice, CD11c+ cells were enriched from
spleens with anti–mouse CD11c microbeads as recommended by the manufacturer (Miltenyi Biotec). Cells were stained with anti–Siglec-H and antiCD11c and then sorted on a FACSAria II high speed cell sorter (BD).
Purities were always >98%.
Apoptosis and cytokine analysis. Spleens were harvested from
control or manipulated mice and cell suspensions were prepared as described. After surface staining, cells were incubated with CaspACE
FITC-VAD-FMK (Promega) or Annexin V (BD) as recommended by the
manufacturer. Serum samples from infected mice were collected at various time points p.i. and IFN- levels were determined by ELISA (PBL
Interferon Source).

RNA preparation and qPCR. RNA was extracted from sorted pDCs
using the RNeasy Micro kit (QIAGEN) as recommended by the manufacturer. cDNA was synthesized from RNA with Superscript III first-strand
synthesis system for RT-PCR (Invitrogen), and relative levels of Bid, Bim,
Puma, Noxa, Bax, Apaf1, Pten, Bcl-xl, and Bcl-2 were determined by qPCR.
SYBR Green PCR master mix (Bio-Rad Laboratories) and an ABI7000
machine (Applied Biosystems) were used according to the manufacturer’s
instructions. PCR conditions were 2 min at 50°C and 10 min at 95°C, followed by 40 two-step cycles consisting of 15 s at 95°C and 1 min at 60°C.
The values of each sample were normalized to GAPDH.
Statistical analysis. The statistical significance of differences in mean values
was analyzed with an unpaired two-tailed Student’s t test. P-values <0.05
were considered statistically significant.
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Tissue samples and immunohistochemistry. Spleens from eight mice/
group (Ctrl and MCMV 36 h p.i.) were analyzed. 5-µm frozen tissue sections were used for immunohistochemical staining to visualize and count
pDCs. For immunohistochemistry, sections were air dried overnight and
fixed in acetone for 10 min. Non-specific binding was prevented using a
protein block (Novocastra Laboratories) for 5 min. Incubation with purified
440c mAb (rat IgG2a) was followed by rat on mouse AP polymer kit (Biocare Medical) and revealed using Ferangi Blue Chromogen (Biocare Medical). The second immune reaction against CD3 antigen (rabbit monoclonal,
clone SP7, dilution 1:100; Thermo Fisher Scientific) was visualized using
Envision Rabbit-HRP (Dako) followed by DAB. Sections were slightly
counterstained with Hematoxylin. For pDC counts, at least 30 high power
fields of white pulp/spleen were counted on two distinct sections (200-µm
distance) stained with 440c. Numbers are expressed as mean ± SD. Digital
images were taken using a microscope (BX60; Olympus) and captured using
a digital camera (DP-70; Olympus) and processed using Analysis Image Processing software (Olympus).
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